Sterling Capital Management »

Y Mabs Therapeutics shares owned by Sterling Capital Management

Quarter-by-quarter ownership of Y Mabs Therapeutics (YMAB) shares owned by Sterling Capital Management from 13F filings

Historical chart of Sterling Capital Management investment in Y Mabs Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Y Mabs Therapeutics held by Sterling Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Y Mabs Therapeutics by Sterling Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $500 38 13.16

More positions owned by Sterling Capital Management

Microsoft Corporation (MSFT)
UnitedHealth (UNH)
Vanguard S&p 500 Etf Etf (VOO)
Hershey Company (HSY)
Automatic Data Processing (ADP)
Home Depot (HD)
Anthem (ELV)
Ameriprise Financial (AMP)
Analog Devices (ADI)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Charles Schwab Corporation (SCHW)
Nasdaq Omx (NDAQ)
Abbvie (ABBV)
Pepsi (PEP)

View all positions for Sterling Capital Management

Top funds holding Y Mabs Therapeutics

Paradigm Biocapital Advisors
BlackRock
BlackRock
Sofinnova Ventures
Vanguard Group
Cormorant Asset Management
Caligan Partners
Geode Capital Management
State Street Corporation
D. E. Shaw & Co
Pictet Asset Management Holding SA
Soleus Capital Management
Dimensional Fund Advisors
Northern Trust
Citadel Advisors

View all funds holding Y Mabs Therapeutics